TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Olink Proteomics AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,425,520
|
1,492,713
|
1,284,315 |
| Financial expenses |
14,063
|
49,450
|
4,479 |
| Earnings before taxes |
-532,317
|
-91,233
|
4,336 |
| EBITDA |
-535,122
|
-15,152
|
23,076 |
| Total assets |
1,743,841
|
1,899,508
|
1,188,106 |
| Current assets |
806,834
|
1,080,986
|
859,606 |
| Current liabilities |
597,678
|
287,497
|
830,681 |
| Equity capital |
1,146,163
|
1,612,011
|
357,425 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
394
|
362
|
289 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.7%
|
84.9%
|
30.1% |
| Turnover per employee |
3,618
|
4,124
|
4,444 |
| Profit as a percentage of turnover |
-37.3%
|
-6.1%
|
0.3% |
| Return on assets (ROA) |
-29.7%
|
-2.2%
|
0.7% |
| Current ratio |
135.0%
|
376.0%
|
103.5% |
| Return on equity (ROE) |
-46.4%
|
-5.7%
|
1.2% |
| Change turnover |
-94,108
|
117,268
|
546,421 |
| Change turnover % |
-6%
|
9%
|
74% |
| Chg. No. of employees |
32
|
73
|
106 |
| Chg. No. of employees % |
9%
|
25%
|
58% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.